arrow
S

Santiago Quirce

hospital la paz
H指数:70
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ARIA-EAACI 2025: Person-Centred, Digitally Enabled and Artificial Intelligence-Assisted Change Management in Airway Diseases

ARIA-EAACI 2025:气道疾病中以患者为中心、数字化赋能和人工智能辅助的变革管理

2026-09-030
OAAI
EAACI Guidelines on Environmental Science for Allergy and Asthma—Evidence-Based Recommendations for Prevention and Public Health Action to Mitigate the Impact of Pollen Exposure on Respiratory Allergy

欧洲过敏与临床免疫学会关于环境科学对过敏和哮喘的指南——基于证据的建议:为预防及公共卫生行动以减轻花粉暴露对呼吸道过敏的影响

2026-06-260
PRE
Rescue Inhaler Overuse in Severe Asthma: A Real-World Study of Short-Acting β2-Agonist and Short-Acting Muscarinic Antagonist Use

严重哮喘患者中急救吸入器的过度使用:短效β2-激动剂和短效毒蕈碱拮抗剂使用的真实世界研究

2026-06-120
OA
A Multi-Compartment Cytological Approach to Severe Asthma Phenotyping: The BRISA Study (Biomedical Research in Severe Asthma)

多腔室细胞学方法对重症哮喘表型分型:BRISA研究(重症哮喘的生物医学研究)

2026-05-250
OAAI
Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines—2024–2025 Revision: Part I—Guidelines on Intranasal Treatments

变应性鼻炎及其对哮喘的影响(ARIA)-EAACI指南—2024–2025年修订版:第一部分—关于鼻内治疗的指南

2025-12-010
OAAI
Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms

过敏性鼻炎及其对哮喘的影响(ARIA)-EAACI 2024–2025指南的开发方法:从证据到决策框架到数字化共享决策算法

2025-11-210
OAAI
Genome-wide Association Study of Asthma Exacerbations in the Spanish Population

哮喘急性发作的西班牙人群全基因组关联研究

2025-03-200
PREAI
FEV1Q as a Predictive Metric for Asthma Outcomes

FEV1Q作为预测哮喘结局的指标

2025-03-010
PRE
EAACI Guidelines on Environmental Science for Allergy and Asthma-Recommendations on the Impact of Indoor Air Pollutants on the Risk of New-Onset Asthma and on Asthma-Related Outcomes

EAACI环境科学指南:过敏与哮喘——关于室内空气污染物对新发哮喘风险及哮喘相关结局影响的建议

2025-02-280
OAAI